Aspiration thrombectomy as the first-line treatment of M2 occlusions

Jan Harsany1, Jozef Haring2, Matus Hoferica1

  • 1Department of Radiology, Faculty Hospital Trnava, Trnava, Slovakia.

Abstract

Insights

Aspiration thrombectomy is a safe and effective treatment for acute ischemic stroke due to M2 occlusions. This study found no significant difference in outcomes between different M2 segment occlusions.

Area of Science:

  • Neurology
  • Interventional Neuroradiology
  • Vascular Neurology

Background:

  • Acute ischemic stroke poses a significant health burden.
  • Occlusions in the M2 segment of the middle cerebral artery present unique treatment challenges.

Purpose of the Study:

  • To evaluate the safety and efficacy of aspiration thrombectomy for M2 occlusions.
  • To compare outcomes across different M2 segment occlusion types.

Main Methods:

  • Retrospective analysis of 82 patients with acute ischemic stroke and M2 occlusions treated with aspiration thrombectomy.
  • Comparison of functional outcomes based on M2 occlusion location.
  • Multivariable logistic regression to identify predictors of good clinical outcome.

Main Results:

  • Aspiration thrombectomy was used as first-line treatment in 72.5% of patients.
  • No statistically significant difference in functional outcomes was observed between different M2 occlusion types.
  • 50% of patients achieved a good clinical outcome (mRS 0-2) at three months.
  • Symptomatic intracranial hemorrhage occurred in 6.1% of patients.
  • Younger age and lower NIHSS scores predicted better outcomes.

Conclusions:

  • Aspiration thrombectomy is a safe and effective first-line treatment for M2 occlusions.
  • It offers a viable therapeutic option for a significant proportion of stroke patients.